CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Utilization of and expenditures for selective serotonin reuptake inhibitors (SSRIs) and factors associated with change in price per-prescription of brand SSRIs in the Texas Medicaid programme (1991-2009)
Author
Anderson
Basu
+37Â more
Berndt
Centers for Medicare and Medicaid Services
Chen
Chen
Congressional Budget Office
Culpepper
Ferrand
Frank
Frank
Grabowski
Greenberg
Henry
Henry
Hirschfeld
Hollis
Hong
Huskamp
IMS Consulting
Johnsrud
Kadiyali
Kessler
Kessler
National Institute for Health Care Management Foundation
Peny
Scott
Statman
Steffens
Stone
Texas Medicaid/CHIP Vendor Drug Program
US Food and Drug Administration
US Food and Drug Administration
US Food and Drug Administration
US Government Printing Office
Weissman
Wolfgang
Wooldridge
World Health Organization
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref